Search Result "SU11274"
Inhibition of c-Met with the Specific Small Molecule Tyrosine Kinase Inhibitor SU11274 Decreases Growth and Metastasis Formation of Experimental Human Melanoma
Journal: Current Cancer Drug Targets
Volume: 10 Issue: 3 Year: 2010 Page: 332-342
Author(s): I. Kenessey, M. Keszthelyi, Z. Kramer, J. Berta, A. Adam, J. Dobos, M. Mildner, B. Flachner, S. Cseh, G. Barna, B. Szokol, L. Orfi, G. Keri, B. Dome, W. Klepetko, J. Timar, J. Tovari
Detection and Therapeutic Implications of c-Met Mutations in Small Cell Lung Cancer and Neuroendocrine Tumors
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 5 Year: 2013 Page: 833-840
Author(s): J. Voortman,T. Harada,R.P. Chang,J.K. Killian,M. Suuriniemi,W.I. Smith,P.S. Meltzer,M. Lucchi,Y. Wang,G. Giaccone
Targeting the C-MET/HGF Signaling Pathway in Pancreatic Ductal Adenocarcinoma
Journal: Current Pharmaceutical Design
Volume: 24 Issue: 39 Year: 2018 Page: 4619-4625
Author(s): Sadaf Ghanaatgar-Kasbi,Shadi Khorrami,Amir Avan,Seyed A. Aledavoud,Gordon A. Ferns
Application of Biological Study for Met Expression to Cancer Therapy
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10 Issue: 1 Year: 2010 Page: 58-63
Author(s): Shinji Osada, Kazuhiro Yoshida
Review of Clinic Trials: Agents Targeting c-Met
Journal: Reviews on Recent Clinical Trials
Volume: 2 Issue: 2 Year: 2007 Page: 143-147
Author(s): Oyewale Abidoye, Nadh Murukurthy, Ravi Salgia
From Concept to Reality: The Long Road to c-Met and RON Receptor Tyrosine Kinase Inhibitors for the Treatment of Cancer
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9 Issue: 2 Year: 2009 Page: 221-229
Author(s): Isabelle Dussault, Steven F. Bellon
The Development of 3-substituted Indolin-2-one Derivatives as KinaseInhibitors for Cancer Therapy
Journal: Current Medicinal Chemistry
Volume: 29 Issue: 11 Year: 2022 Page: 1891-1919
Author(s): Changqing Xu,Yang Liu,Guisen Zhao
Clinical Development of MET Targeted Therapy For Human Cancer
Journal: Current Cancer Therapy Reviews
Volume: 5 Issue: 4 Year: 2009 Page: 261-270
Author(s): Nima Tirgan, Zhe Tang, Patrick C. Ma
Synergistic Activity of the c-Met and Tubulin Inhibitor Tivantinib (ARQ197) with Pemetrexed in Mesothelioma Cells
Journal: Current Drug Targets
Volume: 15 Issue: 14 Year: 2014 Page: 1331-1340
Author(s): Leticia G. Leon,Maria Gemelli,Rocco Sciarrillo,Amir Avan,Niccola Funel,Elisa Giovannetti
Targeting MET Receptor in Rhabdomyosarcoma: Rationale and Progress
Journal: Current Drug Targets
Volume: 18 Issue: 1 Year: 2017 Page: 98-107
Author(s): Barbara Szewczyk,Klaudia Skrzypek,Marcin Majka